ABTI
Alterola Biotech, Inc. [ABTI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ABTI Stock Summary
Top 10 Correlated Stocks
ABTI
In the News
ABTI Financial details
Company Rating
-
Market Cap
7.47M
Income
-1.2M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
01 Jun 2024
P/E
-2.01
Forward P/E
-
PEG
0.25
P/S
-
P/B
-1.19
P/C
-
P/FCF
-4.59
Quick Ratio
-
Current Ratio
0.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-77.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-77.78%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-241%
ROE
-17%
ROC
0.65%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0012-0.0476
52W High
-
52W Low
-
RSI
56.47
Rel Volume
30.52
Avg Volume
5.85K
Volume
178.59K
Perf Week
20%
Perf Month
20%
Perf Quarter
-82%
Perf Half Y
-82%
-
-
-
-
Beta
-0.099
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0036
Change
-37.82%
Company Profile
- Volume Average 5.85K
- Market Capitalization 7.47M
- CEO Mr. David John Hitchcock O.B.E.
- Headquarters Birkenhead,GB
- IPO Date 2010-05-05
-
Website
https://alterola-abti.com 
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.
